sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sarscov
viru
entri
cell
mediat
interact
spike
glycoprotein
angiotensinconvert
enzym
alanin
scan
mutagenesi
analysi
perform
identifi
determin
critic
sarscov
infect
result
indic
charg
amino
acid
residu
import
particular
peptid
repres
variou
region
critic
viru
infect
chemic
synthes
evalu
antivir
activ
two
peptid
aa
exhibit
modest
antivir
activ
ic
respect
one
peptid
compris
two
discontinu
segment
aa
artifici
link
togeth
glycin
exhibit
potent
antivir
activ
ic
novel
peptid
promis
candid
therapeut
agent
deadli
emerg
pathogen
sever
acut
respiratori
syndrom
sar
newli
emerg
diseas
caus
novel
coronaviru
design
sarscov
drosten
et
al
ksiazek
et
al
poutanen
et
al
epidem
close
peopl
infect
worldwid
among
peopl
die
although
epidem
rel
small
scale
viru
major
socioeconom
impact
creat
global
health
concern
sinc
isol
incid
sar
infect
report
link
accident
exposur
viru
laboratori
set
howev
consid
fact
anim
reservoir
harbor
viru
come
close
contact
human
lau
et
al
martina
et
al
viru
highli
like
resurfac
develop
vaccin
andor
antivir
agent
critic
prevent
futur
epidem
entri
sarscov
cell
mediat
spike
glycoprotein
make
attract
target
develop
vaccin
antivir
agent
ie
entri
inhibitor
protein
mani
coronavirus
cleav
function
two
separ
subunit
abraham
et
al
jackwood
et
al
mounir
talbot
subunit
bind
receptor
subunit
induc
fusion
viral
cellular
membran
howev
protein
sarscov
appear
cleav
han
et
al
xiao
et
al
nevertheless
presum
two
function
domain
border
suggest
around
amino
acid
lio
goldman
cellular
receptor
sarscov
identifi
angiotensinconvert
enzymerel
carboxypeptidas
type
integr
membran
protein
amino
acid
contain
one
hexxh
e
zincbind
consensu
sequenc
donoghu
et
al
tipni
et
al
homolog
angiotensinconvert
enzym
ace
play
import
role
reninangiotensin
system
blood
pressur
homeostasi
ace
function
receptor
sarscov
despit
amino
acid
ident
similar
report
dcsignr
protein
relat
dcsign
dendrit
cellspecif
intercellular
adhes
moleculegrab
nonintegrin
could
serv
altern
receptor
jeffer
et
al
find
howev
contradictori
result
anoth
studi
suggest
dcsignr
well
dcsign
enhanc
infect
mediat
function
receptor
marzi
et
al
precis
role
dcsign
dcsignr
sarscov
infect
pathogenesi
yet
elucid
detail
molecular
interact
sarscov
protein
begin
understood
crystal
structur
resolv
towler
et
al
facilit
sar
research
minim
receptorbind
domain
rbd
narrow
amino
acid
fragment
residu
actual
bind
greater
affin
larger
protein
fragment
repres
domain
residu
wong
et
al
recent
sitedirect
mutagenesi
analys
reveal
sever
amino
acid
residu
import
bind
glycoprotein
li
et
al
character
interact
protein
receptor
greater
detail
perform
alanin
scan
mutagenesi
analys
result
reveal
charg
amino
acid
residu
import
viru
infect
appli
inform
design
peptidebas
entri
inhibitor
identifi
one
potent
antivir
activ
result
studi
contribut
better
understand
sarscov
entri
discoveri
novel
antivir
agent
viru
three
gener
region
identifi
import
bind
glycoprotein
residu
loop
li
et
al
amino
acid
shown
fig
c
evalu
determin
interact
glycoprotein
greater
detail
perform
alanin
scan
mutagenesi
analys
focus
charg
amino
acid
residu
two
reason
first
align
amino
acid
sequenc
ace
support
sarscov
infect
reveal
signific
diverg
helic
ident
aa
two
homolog
domain
aa
aa
ace
respect
fig
second
electrostat
attract
predomin
forc
proteinprotein
interact
observ
residu
lesser
degre
glycoprotein
import
bind
wong
et
al
suggest
possibl
interact
opposit
charg
amino
acid
particularli
interest
role
eight
charg
residu
residu
situat
near
imaginari
line
along
amino
acid
alreadi
known
import
bind
protein
fig
total
charg
amino
acid
residu
fig
c
success
mutagen
alanin
except
mutat
introduc
plasmid
encod
fulllength
gene
hela
cell
suscept
sarscov
infect
transfect
plasmid
encod
either
wild
type
mutant
protein
cell
infect
nonrepl
sar
pseudovirus
mulv
pseudotyp
glycoprotein
han
et
al
determin
effect
mutat
viral
entri
disappointingli
mutat
modest
effect
pseudoviru
infect
fig
moreov
surpris
observ
reduct
infect
mutant
sinc
li
et
al
show
near
complet
loss
bind
activ
protein
fragment
contain
mutat
discrep
could
due
differ
pseudoviru
infect
proteinprotein
bind
assay
altern
differ
could
due
use
less
drastic
mutat
studi
ie
k
rather
k
yet
anoth
possibl
viru
adsorpt
period
routin
use
might
long
observ
subtl
differ
wild
type
mutant
protein
explor
whether
differ
wild
type
mutant
viru
entri
kinet
pseudovirus
adsorb
cell
variou
time
min
kinet
analysi
perform
wild
type
mutant
protein
fig
wild
type
rapid
adsorpt
sar
pseudovirus
cell
min
indic
exponenti
increas
viru
titer
viru
titer
continu
increas
min
albeit
slower
rate
maxim
infect
achiev
locat
amino
acid
shown
import
bind
glycoprotein
indic
li
et
al
highlight
yellow
amino
acid
cterminu
shown
refer
c
closeup
view
charg
amino
acid
shown
red
blue
polar
hydrophob
residu
shown
green
white
respect
white
dash
line
repres
imaginari
line
connect
residu
known
import
bind
protein
approxim
min
contrast
infect
mediat
mutant
significantli
slower
took
twice
long
achiev
maxim
infect
min
importantli
differ
pseudoviru
infect
wild
type
protein
pronounc
adsorpt
period
compar
min
littl
differ
observ
adsorpt
period
longer
min
result
suggest
differ
protein
compar
min
rather
min
infect
begin
reach
plateau
therefor
entir
panel
mutant
compar
use
adsorpt
period
condit
mutant
except
exhibit
mark
reduct
abil
support
pseudoviru
infect
fig
reduct
infect
due
defect
protein
express
sinc
mutant
protein
express
level
similar
wt
fig
flow
cytometri
analys
cell
transfect
either
wt
mutant
protein
indic
protein
equal
express
cell
surfac
fig
togeth
result
indic
import
charg
amino
acid
residu
anoth
paramet
could
potenti
affect
infect
sar
pseudovirus
receptor
concentr
depend
mutat
amount
protein
requir
effici
infect
could
differ
similar
mutant
protein
requir
longer
adsorpt
period
greater
amount
mutant
protein
might
necessari
compar
wild
type
test
hypothesi
infect
sar
pseudovirus
hela
cell
transfect
vari
amount
plasmid
encod
either
wild
type
mutant
protein
determin
experi
adsorpt
period
use
expect
sar
pseudoviru
infect
depend
amount
plasmid
use
wild
type
mutant
fig
howev
greater
amount
dna
need
mutant
wild
type
achiev
similar
infect
half
maxim
infect
point
wild
type
mutant
approxim
respect
confirm
express
proport
amount
plasmid
dna
transfect
western
immunoblot
perform
shown
fig
express
correl
amount
dna
transfect
express
level
wild
type
mutant
protein
compar
suggest
diminish
infect
mutant
like
due
reduc
affin
protein
immunoreact
band
approxim
kda
protein
also
detect
overexpos
blot
although
exact
natur
protein
unknown
like
cleavag
product
sinc
band
intens
correl
authent
sinc
differ
infect
wild
type
mutant
greatest
plasmid
dna
use
entir
panel
mutant
evalu
use
pseudoviru
infect
assess
use
two
differ
adsorpt
period
min
adsorpt
period
use
signific
reduct
infect
observ
mutant
fig
use
adsorpt
infect
markedli
reduc
mutant
also
fig
togeth
result
suggest
might
critic
interact
glycoprotein
overal
infect
pattern
similar
adsorpt
period
use
plasmid
dna
fig
compar
fig
consist
result
adsorpt
kinet
analys
fig
mutant
exhibit
defect
support
sar
pseudoviru
infect
know
charg
amino
acid
residu
import
sarscov
entri
next
examin
whether
could
design
peptidebas
viru
entri
inhibitor
ration
peptid
bind
glycoprotein
high
affin
abl
block
protein
interact
inhibit
viru
infect
five
peptid
chemic
synthes
aa
peptid
respect
fig
assess
antivir
activ
pseudovirus
preincub
vari
concentr
peptid
min
allow
infect
hela
cell
express
shown
fig
shorter
peptid
exhibit
weak
antivir
activ
longer
peptid
activ
approxim
inhibitori
concentr
ic
respect
improv
antivir
activ
consid
possibl
incorpor
residu
sinc
also
shown
import
bind
protein
li
et
al
upon
close
examin
crystal
structur
notic
space
suffici
narrow
enough
fill
singl
amino
acid
fig
howev
direction
fragment
opposit
fragment
glycin
smallest
side
chain
high
propens
form
revers
turn
thu
artifici
peptid
amino
acid
synthes
join
fragment
glycin
peptid
fig
surpris
peptid
potent
inhibit
sar
pseudoviru
infect
ic
approxim
lower
peptid
respect
fig
somewhat
unexpect
sinc
differ
eight
amino
acid
slightli
higher
ic
valu
observ
pseudoviru
infect
carri
use
cell
data
shown
inhibitori
effect
specif
sarscov
sinc
none
peptid
inhibit
vsvgpseudotyp
mulv
even
fig
specif
evidenc
fact
none
peptid
effect
virus
pseudotyp
mulv
envelop
protein
data
shown
cytotox
observ
peptid
even
base
neutral
red
uptak
assay
data
shown
studi
examin
import
charg
amino
acid
first
two
mediat
sarscov
infect
total
residu
evalu
eleven
amino
acid
residu
import
two
critic
residu
result
fact
charg
residu
play
import
role
unexpect
given
situat
close
proxim
imaginari
line
connect
amino
acid
previous
shown
import
bind
protein
fragment
li
et
al
fig
regard
bit
surpris
see
import
residu
none
amino
acid
identifi
critic
enough
inhibit
viru
infect
complet
mutant
mere
less
effici
wild
type
requir
either
longer
adsorpt
period
greater
amount
achiev
wild
type
level
infect
expect
sinc
multipl
determin
interact
protein
prepar
manuscript
crystal
structur
bound
protein
fragment
contain
rbd
residu
publish
li
et
al
fig
residu
made
direct
contact
rbd
includ
although
crystal
structur
confirm
result
regard
import
studi
find
includ
mani
residu
found
import
includ
fig
c
particularli
puzzl
fact
neither
two
residu
appear
critic
studi
made
contact
rbd
possibl
reason
could
account
appar
discrep
simplest
explan
result
two
studi
obtain
use
differ
protein
structur
studi
base
small
fragment
protein
contain
rbd
contrast
studi
base
intact
protein
possibl
residu
one
rbd
could
make
contact
amino
acid
identifi
anoth
possibl
explan
conform
receptorbind
motif
rbm
residu
crystal
structur
could
somewhat
differ
one
intact
glycoprotein
previous
shown
mutat
protein
complet
abolish
associ
either
rbd
residu
protein
fragment
residu
wong
et
al
base
result
suspect
residu
might
directli
interact
howev
quit
distant
crystal
structur
fig
seemingli
contradictori
result
rais
possibl
rbd
use
solv
crystal
structur
may
differ
conform
one
use
analyz
mutat
differ
length
prepar
differ
cellular
sourc
insect
cell
vs
human
cell
respect
although
possibl
play
indirect
role
bind
eg
maintain
proper
conform
rbm
littl
difficult
appreci
drastic
effect
amino
acid
far
away
receptorcontact
site
especi
residu
locat
loop
crystal
structur
larger
fragment
need
resolv
issu
third
possibl
reason
discrep
could
differ
natur
two
studi
footprint
analysi
base
crystal
structur
identifi
residu
make
initi
contact
rbd
contrast
studi
examin
entir
viru
entri
process
identifi
residu
function
import
either
directli
indirectli
therefor
residu
identifi
could
involv
initi
bind
glycoprotein
subsequ
step
membran
fusion
process
event
follow
bind
glycoprotein
unknown
addit
studi
necessari
better
understand
molecular
detail
sarscov
entri
studi
examin
antisar
activ
six
chemic
synthes
peptid
deriv
peptid
potent
antivir
activ
compris
two
discontinu
fragment
connect
glycin
peptid
eight
amino
acid
longer
yet
effect
contrast
amino
acid
longer
effect
clear
exactli
much
potent
peptid
simplest
explan
residu
interact
glycoprotein
either
peptid
sitedirect
mutagenesi
analys
indic
amino
acid
import
bind
protein
fragment
li
et
al
furthermor
residu
make
direct
contact
rbm
protein
shown
crystal
structur
li
et
al
thu
four
seven
residu
play
role
viru
infect
contrast
amino
acid
residu
known
involv
bind
mediat
sar
infect
li
et
al
studi
howev
qualit
aspect
interact
could
import
simpli
number
amino
acid
interact
protein
interest
question
remain
answer
whether
peptid
fragment
contain
residu
could
inhibit
sar
infect
assess
antivir
activ
peptid
could
provid
insight
whether
synergi
residu
context
peptid
present
time
understand
neither
peptid
structur
interact
glycoprotein
peptid
fold
structur
appear
crystal
structur
peptid
bind
rbm
illustr
fig
contact
site
protein
would
includ
residu
possibl
howev
may
fold
slightli
differ
free
peptid
one
thing
residu
form
highli
amphipath
one
side
helix
bind
protein
highli
polar
mani
charg
amino
acid
opposit
side
face
interior
hydrophob
fig
hydrophob
amino
acid
would
expos
aqueou
environ
free
peptid
might
make
structur
less
stabl
secondli
although
residu
part
structur
intact
might
exist
conform
due
absenc
residu
support
format
fig
structur
analys
interact
rbd
bird
eye
view
crystal
structur
rbd
protein
lime
bound
gray
li
et
al
rbm
portion
rbd
color
pink
surfac
amino
acid
actual
make
contact
shown
purpl
first
two
shown
yellow
refer
residu
make
contact
rbm
shown
green
charg
residu
shown
import
pseudoviru
infect
studi
shown
either
red
blue
b
top
view
cocryst
structur
residu
shown
import
infect
shown
make
contact
rbd
indic
c
side
view
cocryst
structur
posit
residu
protein
shown
orang
potenti
bind
site
peptid
rbd
peptid
fragment
shown
yellow
cyan
respect
rbm
shown
pink
rest
rbd
shown
lime
secondari
structur
regardless
potent
antivir
activ
peptid
suggest
conform
like
resembl
one
crystal
structur
least
bound
protein
shown
interact
glycoprotein
play
critic
role
sar
pathogenesi
kuba
et
al
bind
protein
lead
downregul
receptor
result
deregul
reninangiotensin
system
eventu
lung
injuri
therefor
peptid
strong
therapeut
candid
would
inhibit
sarscov
infect
also
prevent
sever
often
lethal
lung
failur
plasmid
encod
fulllength
wild
type
human
gener
provid
dr
michael
farzan
sitedirect
mutagenesi
perform
use
quickchangexl
sitedirect
mutagenesi
system
stratagen
pfuturbo
dna
polymeras
fourteen
pair
primer
use
gener
mutant
primer
nucleotid
long
nucleotid
chang
amino
acid
mutat
indic
follow
gag
gcg
gaa
gca
aag
gcg
gac
gcc
aag
gcg
cac
gcc
gaa
gca
gaa
gca
gac
gcc
gaa
gca
gag
gcg
aaa
gca
aag
gcg
gaa
gca
mutat
verifi
sequenc
cell
line
schnierl
et
al
hela
maintain
dulbeco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
mm
lglutamin
penicillinstreptomycin
antibiot
cell
cultur
co
incub
pseudovirus
encod
produc
previous
describ
han
et
al
briefli
cell
continu
releas
murin
leukemia
viru
mulv
particl
transfect
plasmid
encod
glycoprotein
phcmv
han
et
al
g
glycoprotein
vesicular
stomat
viru
phcmvg
burn
et
al
use
lipofectin
invitrogen
per
manufactur
protocol
three
day
posttransfect
cell
cultur
medium
harvest
subject
centrifug
min
remov
cell
debri
supernat
aliquot
store
use
viru
stock
produc
pseudovirus
without
repeat
transfect
gener
cell
stabli
express
glycoprotein
cell
cotransfect
phcmv
invitrogen
encod
neomycin
resist
gene
transfect
cell
select
growth
medium
contain
geneticin
invitrogen
geneticinresist
clone
isol
expand
abl
produc
high
titer
sar
pseudovirus
select
although
cell
subsequ
maintain
absenc
geneticin
continu
produc
pseudovirus
titer
per
ml
viru
titer
determin
cell
pseudoviru
infect
done
cell
plate
hela
cell
plate
transfect
plasmid
encod
either
wild
type
mutant
protein
cell
transfect
indic
amount
plasmid
dna
per
well
use
lipofectin
overnight
incub
cultur
medium
replac
approxim
h
posttransfect
cell
infect
infecti
unit
pseudovirus
pseudovirus
allow
adsorb
onto
cell
variou
time
indic
cell
subsequ
wash
pb
remov
unadsorb
virus
fresh
medium
ad
infect
allow
proceed
addit
day
time
infect
cell
stain
xgal
previous
describ
han
et
al
although
blue
cell
detect
within
hour
stain
routin
done
overnight
yield
stronger
signal
pseudovirusinfect
cell
quantifi
visual
use
invert
microscop
peptid
synthes
fmoc
strategi
omega
synthes
advanc
chemtech
louisvil
ky
use
solid
phase
chemistri
synthesi
perform
coupl
amino
acid
ester
use
diisopropylcarbodiimid
aminoand
carboxyltermini
acetyl
amid
respect
deprotect
nafmoc
group
accomplish
piperidin
dimethylformamid
synthesi
peptid
cleav
solid
support
deprotect
use
modifi
reagent
k
cocktail
consist
tfa
thioanisol
ethanedithiol
water
phenol
cocktailcontain
peptid
filter
quicksnap
column
filtrat
collect
ml
icecold
butan
ether
peptid
precipit
h
centrifug
wash
twice
icecold
methyltbutyl
ether
peptid
dissolv
acetonitril
lyophil
complet
dri
powder
expect
molecular
weight
peptid
verifi
matrixassist
laser
desorpt
ioniz
timeofflight
malditof
mass
spectrometri
peptid
dissolv
pb
mm
depend
peptid
store
use
evalu
antivir
activ
pseudovirus
sarss
vsvg
preincub
indic
concentr
peptid
min
subsequ
viruspeptid
mixtur
ad
cell
hela
cell
transfect
plasmid
encod
wild
type
adsorpt
period
viru
inoculum
remov
fresh
cultur
medium
ad
follow
addit
day
infect
infect
cell
stain
virusinfect
cell
quantifi
describ
hela
cell
grown
plate
transfect
indic
amount
plasmid
dna
encod
either
wild
type
mutant
use
lipofectin
overnight
incub
cultur
medium
replac
h
posttransfect
cultur
medium
remov
cell
lyse
hypoton
buffer
contain
nonion
deterg
mm
tri
ph
mm
nacl
mm
mgcl
nuclei
insolubl
cell
debri
remov
centrifug
cell
lysat
subject
sdspage
follow
electrotransf
nitrocellulos
membran
western
blot
protein
detect
rabbit
polyclon
antibodi
inc
follow
goat
antirabbit
igg
conjug
horseradish
peroxidas
pierc
protein
band
visual
supersign
chemiluminesc
substrat
pierc
accord
manufactur
protocol
flow
cytometri
transfect
cell
harvest
scrape
cultur
medium
centrifug
cell
wash
twice
pb
resuspend
stain
buffer
bd
pharmingen
contain
mous
igg
antihuman
ectodomain
monoclon
antibodi
r
system
stain
h
cell
wash
three
time
pb
resuspend
stain
buffer
contain
goatanti
mous
igg
conjug
fitc
bd
pharmingen
stain
h
cell
wash
three
time
pb
resuspend
pb
subject
flow
cytometri
analysi
use
bd
facscalibur
